# Rheumatology * **Definition:** A branch of medicine that focuses on the diagnosis and treatment of rheumatic diseases, which often involve inflammation and pain in the muscles, joints, or connective tissues. * **Taxonomy:** Specialties / Rheumatology ## News * Selected news on the topic of **Rheumatology**, for healthcare technology leaders * 3K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/22/2025 | [**New approach to evaluating cases with rheumatic reactions to cancer immunotherapy**](https://medicalxpress.com/news/2025-05-approach-cases-rheumatic-reactions-cancer.html) | [[MedicalXpress]] | | 5/21/2025 | [**Rheumatology News**](https://www.medscape.com/index/list_11823_0) | [[Medscape]] | | 5/16/2025 | [**Shaping the Future of Rheumatology Trials: Operational Strategies, Industry Trends and Breakthroughs in Cell and Gene Therapies, Upcoming Webinar Hosted by Xtalks**](https://www.prweb.com/releases/shaping-the-future-of-rheumatology-trials-operational-strategies-industry-trends-and-breakthroughs-in-cell-and-gene-therapies-upcoming-webinar-hosted-by-xtalks-302456163.html) | [[PRWeb]] | | 5/1/2025 | [**ACR, CARRA Issue First-Ever Pediatric Rheumatology Mental Health Guidance**](https://www.medscape.com/viewarticle/acr-carra-issue-first-ever-pediatric-rheumatology-mental-2025a1000ap5) | [[Medscape]] | | 4/28/2025 | [**The billion-dollar question every pharmacy executive will face in 2025**](https://www.beckershospitalreview.com/hospital-management-administration/the-billion-dollar-question-every-pharmacy-executive-will-face-in-2025/) | [[Beckers Hospital Review]] | | 4/14/2025 | [**Major Barriers Hinder Pediatric Neuropsychiatric Lupus Care**](https://www.medscape.com/viewarticle/major-barriers-hinder-pediatric-neuropsychiatric-lupus-care-2025a10008th) | [[Medscape]] | | 4/10/2025 | [**Articularis Rheumatology Specialists of Atlanta Welcomes Leading Rheumatologist, Dr ...**](https://www.prnewswire.com/news-releases/articularis-rheumatology-specialists-of-atlanta-welcomes-leading-rheumatologist-dr-douglas-white-302425772.html) | [[PR Newswire]] | | 4/10/2025 | [**Articularis Rheumatology Specialists of Atlanta Welcomes Leading Rheumatologist, Dr. Douglas White**](https://finance.yahoo.com/news/articularis-rheumatology-specialists-atlanta-welcomes-144600070.html) | [[Yahoo Finance]] | | 3/27/2025 | [**Remote Patient Monitoring Is the Future in Rheumatology, But What's Holding It Back?**](https://www.medscape.com/viewarticle/remote-patient-monitoring-future-rheumatology-whats-holding-2025a10007dp) | [[Medscape]] | | 2/20/2025 | [**analytics Coverage - MedCity News**](https://medcitynews.com/tag/analytics/?__hstc=173697148.aec075439bbbb84313a0cbcedd106694.1724976000172.1724976000173.1724976000174.1&__hssc=173697148.1.1724976000175&__hsfp=2420521548) | [[MedCity News]] | | 12/23/2024 | [**XBiotech halts all rheumatology research after missing Phase II endpoints**](https://finance.yahoo.com/news/xbiotech-halts-rheumatology-research-missing-144604222.html) | [[Yahoo Finance]] | | 12/8/2024 | [**Rheumatology Match: Pediatric Programs Continue to Struggle**](https://www.medscape.com/viewarticle/rheumatology-match-pediatric-programs-continue-struggle-2024a1000mmb) | [[Medscape]] | | 12/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827395) | [[JAMA Network]] | | 11/19/2024 | [**Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy**](http://www.businesswire.com/news/home/20241119155706/en/Innovaderm-Research-Appoints-Ina-Zschocke-as-New-Executive-Vice-President-European-Operations-and-Strategy/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/19/2024 | [**Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European ...**](https://www.businesswire.com/news/home/20241119155706/en/Innovaderm-Research-Appoints-Ina-Zschocke-as-New-Executive-Vice-President-European-Operations-and-Strategy) | [[Business Wire]] | | 11/15/2024 | [**Rheumatology Associates of Oklahoma implements eClinicalWorks AI solution**](https://finance.yahoo.com/news/rheumatology-associates-oklahoma-implements-eclinicalworks-123110047.html) | [[Yahoo Finance]] | | 11/14/2024 | [**Leading Rheumatology Practice Reports Significant Time Savings Utilizing eClinicalWorks Image AI**](http://www.businesswire.com/news/home/20241114874425/en/Leading-Rheumatology-Practice-Reports-Significant-Time-Savings-Utilizing-eClinicalWorks-Image-AI/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/14/2024 | [**Leading Rheumatology Practice Reports Significant Time Savings Utilizing eClinicalWorks Image AI**](http://www.businesswire.com/news/home/20241114874425/en/Leading-Rheumatology-Practice-Reports-Significant-Time-Savings-Utilizing-eClinicalWorks-Image-AI/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 11/14/2024 | [**Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting**](https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-to-present-at-american-college-of-rheumatology-convergence-2024-annual-meeting-302306094.html) | [[PR Newswire]] | | 11/11/2024 | [**MedAdvisor adds mobile telehealth feature and more briefs - MobiHealthNews**](https://www.mobihealthnews.com/news/anz/medadvisor-adds-mobile-telehealth-feature-and-more-briefs) | [[MobiHealthNews]] | | 10/31/2024 | [**Rheumatology in the digital health era: status quo and quo vadis? - Nature**](https://www.nature.com/articles/s41584-024-01177-7) | [[Nature]] | | 9/18/2024 | [**Innovaderm Research Welcomes Dr Juan Gabriel Ovalles Bonilla, MD, PhD as Medical Rheumatology Lead, Expanding its Reach into this Field**](http://www.businesswire.com/news/home/20240917759776/en/Innovaderm-Research-Welcomes-Dr-Juan-Gabriel-Ovalles-Bonilla-MD-PhD-as-Medical-Rheumatology-Lead-Expanding-its-Reach-into-this-Field/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/18/2024 | [**How private credit is filling the void left behind by banks**](https://finance.yahoo.com/video/private-credit-filling-void-left-172126401.html) | [[Yahoo Finance]] | | 7/18/2024 | [**Gaps in Rheumatoid Arthritis Care Quality Exist in North America**](https://www.ajmc.com/view/gaps-in-rheumatoid-arthritis-care-quality-exist-in-north-america) | [[AJMC]] | | 6/17/2024 | [**Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin**](https://www.prnewswire.com/news-releases/progentec-diagnostics-announces-appointment-of-immunology-expert-dr-bernard-rubin-302174569.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Rheumatology Research Foundation**: A foundation that funds research and education in rheumatology to improve patient care. - **Articularis Rheumatology Specialists**: A healthcare provider focused on delivering comprehensive rheumatologic care with advanced medical technology. - **Articularis Healthcare Group**: A physician-led organization providing operational services to private practice rheumatologists, enhancing patient care. - **American College of Rheumatology (ACR)**: A professional organization that provides education, research, and advocacy for rheumatology professionals. - **Key Player**: Rheumatology Research Foundation, Definition: The largest private funding source for rheumatology research and training in the U.S. - **European League Against Rheumatism (EULAR)**: A European organization focused on improving the treatment and prevention of rheumatic diseases. - **Dr. Kim Lauper**: Lead researcher from Geneva University Hospitals focusing on gender representation in rheumatology RCTs. - **Scipher Medicine**: A biotechnology company focused on precision medicine for autoimmune diseases, particularly rheumatoid arthritis, utilizing genomic data to inform treatment decisions. - **Dr. Giulio Superti-Furga**: Researcher developing a precision medicine method for rheumatoid arthritis therapy selection. - **ROPCA**: A Danish company that developed the ARTHUR automated ultrasound scanning system for assessing rheumatoid arthritis disease activity. - **Arthrosi Therapeutics, Inc.**: A biopharmaceutical company focused on developing treatments for gout, notably AR882, which has shown promising clinical results. - **Dr. Robert T. Keenan**: Chief Medical Officer at Arthrosi Therapeutics, focusing on gout treatment with AR882. - **Aqtual, Inc.**: A company developing a blood-based test for rheumatoid arthritis therapy selection, utilizing cell-free DNA to enhance personalized treatment strategies. - **Dr. Rebecca T. Brooks**: Researcher linking rheumatoid arthritis to increased lung cancer risk. - **AffyImmune Therapeutics**: A biotechnology company focused on developing CAR T cell therapies for various diseases, including rheumatological conditions. ### Partnerships and Collaborations - **ACR and NIAMS**: Collaborate on research initiatives to advance understanding and treatment of rheumatic diseases. - **Collaboration between pharmaceutical companies and academic institutions**: Joint efforts to develop new therapies and conduct clinical trials for rheumatic diseases. - **Pharmaceutical companies and academic institutions**: Engage in partnerships to develop new therapies and clinical trials for rheumatic conditions. - **Partnerships between pharmaceutical companies and academic institutions**: These collaborations focus on developing new therapies and clinical trials for rheumatic diseases. - **GHLF and ACR**: GHLF collaborates with the American College of Rheumatology to present research focused on improving care for chronic inflammatory diseases. - **Collaborations with technology firms**: To create digital health tools that assist in monitoring and managing rheumatic conditions. - **Innovaderm Research and Dr. Juan Gabriel Ovalles Bonilla**: Appointment of a board-certified rheumatologist to enhance research capabilities in rheumatology. - **Scipher Medicine and Atropos Health**: A strategic partnership aimed at enhancing precision medicine for rheumatoid arthritis by integrating diagnostic data into evidence-generating solutions. - **Global Healthy Living Foundation (GHLF)**: Collaborating with the American College of Rheumatology to present innovative research on chronic inflammatory diseases. - **Scipher Medicine and Roivant**: A collaboration to enhance drug discovery in rheumatology by integrating real-world clinical and genomic data insights. - **eClinicalWorks and Rheumatology Associates of Oklahoma**: Implemented AI solutions to enhance clinical efficiency and improve patient care. - **EULAR Network of TRIal Centres (ENTRI)**: An initiative to enhance research in rheumatic diseases by creating a network of clinical trial centers across Europe. - **FAIRVASC project**: Collaboration between researchers from Trinity College Dublin and Lund University to improve systemic vasculitis diagnosis and treatment. - **Lupus Therapeutics and Lupus Clinical Investigators Network**: Collaboration to enhance the quality and efficiency of lupus research. - **MVHC and AndHealth**: Partnering to provide Whole-Person Specialty Care and specialty pharmacy services to improve access to rheumatology care in rural Ohio. - **UCB and Biogen**: Collaboration to evaluate dapirolizumab pegol as a treatment for systemic lupus erythematosus. - **Mayo Clinic and Microsoft Research**: Developing generative AI to enhance diagnostic accuracy and personalize patient care. - **BioXcellerator's Health Advisory Board**: Composed of esteemed scientists and medical experts, this board aims to drive innovation in regenerative medicine and improve patient quality of life. - **Public-private partnerships**: Collaborations aimed at advancing research and improving patient access to innovative treatments. ### Innovations, Trends, and Initiatives - **Telemedicine in Rheumatology**: The adoption of telehealth services to provide remote consultations and follow-ups for patients with rheumatic diseases. - **AI in Rheumatology**: Innovations in AI applications for improving diagnostic processes and treatment recommendations for conditions like rheumatoid arthritis. - **ACR Convergence 2024**: The annual meeting will showcase hundreds of sessions on rheumatology, including new research findings and discussions on workforce shortages. - **RISE Registry**: A registry initiated by ACR to evaluate the quality of care in rheumatology practices, showing significant improvements in care quality for rheumatoid arthritis. - **EULAR 2024-2029 Manifesto**: A coordinated response to Rheumatic and Musculoskeletal Diseases (RMDs) in Europe, emphasizing prevention, early diagnosis, and treatment. - **Therapeutic Drug Monitoring (TDM)**: Increasing recognition among rheumatologists for managing patients on DMARDs, with a focus on precision medicine. - **Digital Health Technologies**: Emerging technologies are reshaping the patient pathway in rheumatology, including remote monitoring and hybrid care models. - **Pharmacoscopy**: A new precision medicine method for direct measurement of drug effects on immune cells in rheumatoid arthritis. - **PatientSpot**: Celebrating its 10th anniversary, this platform aims to enhance patient engagement and education in rheumatology. - **Artificial Intelligence (AI) in Diagnosis**: Utilization of AI algorithms to assist in the early diagnosis and treatment planning for rheumatic conditions. - **Biologic Drugs for Rheumatoid Arthritis**: Recent studies indicate that rheumatoid arthritis patients with a history of solid tumors do not face an increased risk of cancer recurrence when treated with biologic drugs compared to conventional disease-modifying agents. - **PrismRA Diagnostic**: A precision medicine diagnostic tool developed by Scipher Medicine that uses genomic markers to identify rheumatoid arthritis patients unlikely to respond to specific therapies. - **New Draft Guidance on MSUS**: ACR's updated guidance for musculoskeletal ultrasound aimed at improving diagnosis and monitoring of rheumatoid arthritis. - **Remote Therapeutic Monitoring (RTM)**: Research highlights the effectiveness of RTM in managing musculoskeletal diseases, showing high patient satisfaction and potential for proactive disease management. - **Aqtual's Therapy Selection Test**: A blood-based test for rheumatoid arthritis therapy selection, aiming for commercialization by 2025. - **Artificial Intelligence (AI) in Diagnostics**: AI technologies are being developed to assist in the diagnosis and management of rheumatic diseases, enhancing accuracy and efficiency. ### Challenges and Concerns - **Health Disparities**: Urgent need to address structural barriers to equitable healthcare access in rheumatic diseases. - **Healthcare Workforce Shortage**: A critical shortage of healthcare professionals in rheumatology is exacerbated by an aging population and rising costs. - **Access to Rheumatology Care**: Patients face challenges due to a scarcity of rheumatologists, necessitating innovative solutions like remote monitoring. - **Access to Care**: Many patients face barriers to accessing rheumatology care, including geographic limitations and insurance coverage issues. - **Quality of Care for Rheumatoid Arthritis**: Identified barriers include delays in seeking medical advice, poor adherence to therapy, and unsatisfactory patient-reported outcomes. - **Workforce Shortages**: There is a growing concern about the shortage of rheumatologists, which may impact patient care and access. - **Pediatric Rheumatology Workforce**: Concerns over the low fill rates for pediatric rheumatology fellowship positions, indicating potential future workforce shortages. - **Access to care**: Many patients face barriers to accessing specialized rheumatology care, particularly in rural areas. - **Reimbursement Issues**: Physician practices face disruptions due to declining reimbursements and prior authorization burdens, impacting the delivery of care for rheumatology patients. - **Gender Representation in RCTs**: Significant underrepresentation of women as authors in rheumatology RCTs, particularly in industry-funded studies. - **Literacy Levels in Patient Education**: A study indicates that patient education materials in rheumatology require a higher literacy level than recommended, posing challenges for patient understanding. - **Recruitment and Retention of PAs**: The need to effectively recruit, retain, and support physician assistants in rheumatology to ensure efficient practice operations. - **Patient Education Materials**: A study highlighting that rheumatology patient education materials require higher literacy levels than recommended, impacting patient understanding and health outcomes. - **Adoption of TDM**: Limited adoption of TDM in rheumatology due to insufficient evidence, lack of clinical guidelines, and inconsistent assay standards. - **Clinical Trial Design for Pediatric Rheumatology**: Current trial designs are criticized for inadequacy in addressing the needs of children with juvenile idiopathic arthritis, highlighting ethical concerns. - **Regulatory and Reimbursement Issues**: Barriers hindering the implementation of digital health technologies in rheumatology despite their potential benefits. - **Rising Drug Costs**: The high cost of biologic therapies for rheumatic diseases poses a significant challenge for patients and healthcare systems. - **AI Limitations**: Concerns regarding the accuracy of AI systems in rheumatology, with potential risks of misinformation leading to patient harm. - **Combined Clinics Challenges**: Staffing issues, space limitations, and reimbursement concerns hinder the effective operation of combined dermatology and rheumatology clinics. - **Need for Comprehensive Treatment Options**: Research indicates a reliance on steroids for treating polymyalgia rheumatica, highlighting the need for better treatment options. ## Related Topics [[Pediatric Rheumatology]]